SMARCA2 and non-small cell lung carcinoma: Two polymorphic insertion promoter sequence variants in SMARCA2, prevalent in 20% of Caucasians, were strongly correlated with the loss of SMARCA2 in both NSCLC cell lines and primary NSCLC cells.